New imaging approach could speed up cancer drug testing

Researchers developed a microscopy-based method to monitor how breast cancer cells respond to treatment in real time, potentially accelerating drug development. The technique tracks physical changes in tumor-like structures, offering a faster, cheaper alternative to traditional testing that could help pharmaceutical companies evaluate promising therapies more efficiently.

Originaltitel: Microscopy-based phenotypic monitoring of MDA-MB-231 spheroids allows the evaluation of phenotype-directed therapy